INmune Bio advances Ebstrocel toward EMA marketing authorization
INmune Bio says it has advanced Ebstrocel toward European marketing authorization via EMA regulatory filings, per TradeXchange Newsdesk.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.